Page 113 - MemoriaCIBER-2017ESP
P. 113
        Brindle KM, Izquierdo-García JL, Lewis DY, Mair RJ, Wright AJ  Brain Tumor Imaging  Journal of clinical oncology: o cial journal of the American Society of Clinical Oncology  2017;35(21) 
  24,008
 Drager LF, McEvoy RD, Barbe F, Lorenzi-Filho G, Redline S, INCOSACT Initiative (International Collaboration of Sleep Apnea Cardiovascular Trialists)   Sleep Apnea and Cardiovascular Disease: Lessons From Recent Trials and Need for Team Science  Circulation  2017;136(19) 
19,309
 Cullinan P , Munoz X , Suojalehto H , Agius R , Jindal S , Sigsgaard T  et al  Occupational lung diseases: From old and novel exposures to e ective preventive strategies  The Lancet Respiratory Medicine  2017 
  19,287
           Rello J  Theranostics in severe in uenza  The Lancet Respiratory Medicine  2017  19,287
Patentes CIBERES 2017 Solicitadas
• “Método in vitro para identi car escalones de gravedad en pacientes con asma bronquial”  (P201730739) 
• “Method for predicting response to continuous positive air pressure treatment” (EP 15817217 1 Europa, CA2970703 Canadá, JP2017-533495 Japón, AU 2015367460 Australia, 15/535,731 USA) 
Concedidas
• “Micobacterias inactivadas para su uso por vía oral en la prevención de la tuberculosis” Fecha concesión: 28/2/2017 inventores: Cardona Iglesias, Pere-Joan; Vilaplana Massaguer, Cristina; Marzo Escartín, Elena Cotitularidad: Institut germansTries i Pujol (IGTP) 66,7%/ CIBERES 33,3% (US9579371) 
Guías clínicas
• Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary.
• Manual SEPAR de Procedimientos  Gasometría Arterial 
• An O cial American Thoracic Society Workshop Report: Noninvasive Identi cation of Inspiratory
Flow Limitation in Sleep Studies.
• Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline.
• International Guidelines for the Management of Hospital-Acquired Pneumonia (HAP) and Ventilator-Associated Pneumonia.
• Guidelines for the Management of HAP/VAP of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESCIM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociación Latino-americana del Tórax (ALAT).
• Normativa sobre el tratamiento farmacológico de la  brosis pulmonaridiopática 
    Agusti A , Dekhuijzen P R  Maximal bronchodilation: a therapeutic target in COPD? The Lancet Respiratory Medicine  2017;5(7):540-542 
 19,287
   











































































   111   112   113   114   115